{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:23:13Z","timestamp":1778008993497,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.phrs.2016.01.032","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T06:15:28Z","timestamp":1454825728000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation"],"prefix":"10.1016","volume":"106","author":[{"given":"Antonietta","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorentina","family":"Roviezzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan K.","family":"Zjawiony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo A.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2016.01.032_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/02791072.1994.10472441","article-title":"Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin), A","volume":"26","author":"Vald\u00e9s","year":"1994","journal-title":"J. Psychoactive Drugs."},{"issue":"5","key":"10.1016\/j.phrs.2016.01.032_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/mi.6.5.7","article-title":"Salvinorin A: from natural product to human therapeutics","author":"Vortherms","year":"2006","journal-title":"Mol. Interv."},{"issue":"18","key":"10.1016\/j.phrs.2016.01.032_bib0015","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring non nitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2016.01.032_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-010-1834-7","article-title":"Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats","volume":"210","author":"Nemeth","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.phrs.2016.01.032_bib0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.110.003244","article-title":"Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A","volume":"63","author":"Cunningham","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.032_bib0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.104.073668","article-title":"Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo","volume":"312","author":"Wang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2016.01.032_bib0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/jpet.106.101998","article-title":"Antinociceptive and hypothermic effects of salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice","volume":"318","author":"Ansonoff","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2016.01.032_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2011.10.026","article-title":"Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology","volume":"121","author":"Lamb","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2016.01.032_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1744-8069-8-60","article-title":"Salvinorin A reduces mechanical allodynia and spinal neuron alhyperexcitability induced by peripheral formalin injection","volume":"8","author":"Guida","year":"2012","journal-title":"Mol. Pain"},{"issue":"9","key":"10.1016\/j.phrs.2016.01.032_bib0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00109-011-0752-4","article-title":"Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo","volume":"89","author":"Aviello","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.phrs.2016.01.032_bib0055","first-page":"e212","article-title":"Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum","author":"Fichna","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"issue":"6","key":"10.1016\/j.phrs.2016.01.032_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ibd.21873","article-title":"Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors","author":"Fichna","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2016.01.032_bib0065","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2016.01.032_bib0070","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/bph.12625","article-title":"The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo bytargeting 5-lipoxygenase-activating protein (FLAP)","volume":"171","author":"Pergola","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.032_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2982.2005.00725.x","article-title":"The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum","volume":"18","author":"Capasso","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"issue":"26","key":"10.1016\/j.phrs.2016.01.032_bib0080","doi-asserted-by":"crossref","first-page":"20146","DOI":"10.1074\/jbc.M908941199","article-title":"Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that Do and Do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation","volume":"275","author":"Gij\u00f3n","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2016.01.032_bib0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","article-title":"The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages","volume":"161","author":"Rossi","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2016.01.032_bib0090","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/cmi.12312","article-title":"Myeloperoxidase in human neutrophil host defence","author":"Nauseef","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.phrs.2016.01.032_bib0095","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","article-title":"Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker","volume":"78","author":"Bradley","year":"1982","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.032_bib0100","first-page":"81","article-title":"Assessment of myeloperoxidase activity in renal tissue after ischemia\/reperfusion","volume":"292","author":"Laight","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.01.032_bib0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0015-0282(03)00975-0","article-title":"Functional and morphologic evaluation of the nasal mucosa before and after hormone therapy in postmenopausal women with nasal symptoms","volume":"80","author":"Nappi","year":"2003","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.phrs.2016.01.032_bib0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.GME.0000113849.74835.53","article-title":"Comparison of intranasal and transdermal estradiol on nasal mucosa in postmenopausal women","volume":"11","author":"Nappi","year":"2004","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.phrs.2016.01.032_bib0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1096\/fj.02-0815fje","article-title":"Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by non redox-type inhibitors","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.032_bib0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1073\/pnas.92.1.107","article-title":"Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3","volume":"92","author":"Brungs","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.01.032_bib0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.2011.01605.x","article-title":"On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivo","volume":"165","author":"Pergola","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.phrs.2016.01.032_bib0130","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.032_bib0135","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3565(25)38889-0","article-title":"In vivo characterization of zymosan-induced mouse peritoneal inflammation","volume":"269","author":"Rao","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.01.032_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1014837110735","article-title":"Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes","volume":"26","author":"Kolaczkowska","year":"2002","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2016.01.032_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.05.011","article-title":"In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis","volume":"87","author":"Rossi","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.01.032_bib0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0076-6879(09)05417-2","article-title":"Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation","volume":"461","author":"Cash","year":"2009","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.phrs.2016.01.032_bib0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2982.2007.00994.x","article-title":"The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice","volume":"20","author":"Capasso","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"issue":"5","key":"10.1016\/j.phrs.2016.01.032_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/bjp.2008.294","article-title":"Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors","volume":"155","author":"Capasso","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.032_bib0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"5","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.phrs.2016.01.032_bib0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/labinvest.3700276","article-title":"5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration","volume":"85","author":"Cuzzocrea","year":"2005","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2016.01.032_bib0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/joim.12367","article-title":"Regulation of atherosclerotic plaque inflammation","volume":"278","author":"B\u00e4ck","year":"2015","journal-title":"J. Intern. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:51:36Z","timestamp":1748771496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815301808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":35,"alternative-id":["S1043661815301808"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.032","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}